Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
358
datasets available to search
ShareScore release 0.9.0
Dataset results
358 results for “SAR studies”
Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study
ClinicalTrials.gov study NCT04579471. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection
ClinicalTrials.gov study NCT05196477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: "Proof of Concept" Study (CoviDetectionDog)-Covid-19
ClinicalTrials.gov study NCT04970563. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-1
ClinicalTrials.gov study NCT05894499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)
ClinicalTrials.gov study NCT04448769. IPD Sharing: YES. Countries: 1. Publications: 0.
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
ClinicalTrials.gov study NCT05550142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
ClinicalTrials.gov study NCT04483908. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older
ClinicalTrials.gov study NCT05501522. IPD Sharing: NO. Countries: 2. Publications: 0.
Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)
ClinicalTrials.gov study NCT00807053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19
ClinicalTrials.gov study NCT04659239. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
ClinicalTrials.gov study NCT04721535. IPD Sharing: NO. Countries: 1. Publications: 0.
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
ClinicalTrials.gov study NCT05050474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospit
ClinicalTrials.gov study NCT04528901. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).
ClinicalTrials.gov study NCT04441385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
ClinicalTrials.gov study NCT04758273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2
ClinicalTrials.gov study NCT06283459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy
ClinicalTrials.gov study NCT04402918. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.
ClinicalTrials.gov study NCT06360744. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine
ClinicalTrials.gov study NCT05894525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against Coronavirus
ClinicalTrials.gov study NCT05104840. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.